GCIA
STJ

Gabelli & Co Investment Advisers’s St Jude Medical STJ Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-493,527
Closed -$39.6M – 188
2016
Q4 		$39.6M Buy
493,527
+162,214
+49% +$12.9M 4.59% 3
2016
Q3 		$26.4M Buy
331,313
+6,500
+2% +$525K 3.09% 3
2016
Q2 		$25.3M Buy
+324,813
New +$23.2M 3.3% 3

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Gabelli & Co Investment Advisers's STJ Position: Q1 2017 in Review

Gabelli & Co Investment Advisers sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 493,527 shares — an estimated $39.6M sold.

Gabelli & Co Investment Advisers first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $39.6M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Gabelli & Co Investment Advisers reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 493,527 St Jude Medical shares in Q1 2017, an estimated $39.6M.
  • Gabelli & Co Investment Advisers first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Gabelli & Co Investment Advisers's St Jude Medical position peaked at $39.6M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2017, filed 4 May 2017.